Glenmark Pharmaceuticals is recalling 1,476,048 bottles of Atomoxetine Capsules (atomoxetine) sold under the Glenmark and Northstar brands. This recall is due to the presence of an impurity called N-nitroso atomoxetine at levels exceeding those recommended by the FDA. If you use this medication to treat ADHD, speak with your doctor or pharmacist about these recalled batches.
N-nitroso atomoxetine is considered a probable human carcinogen, and long-term exposure above safety limits may increase the risk of developing cancer.
You have 2 options:
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.